Willow Biosciences (TSE:WLLW) Stock Price Down 12.5% – Here’s Why

Willow Biosciences Inc. (TSE:WLLWGet Free Report) fell 12.5% during trading on Thursday . The stock traded as low as C$0.04 and last traded at C$0.04. 112,000 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 493,814 shares. The stock had previously closed at C$0.04.

Willow Biosciences Stock Performance

The stock has a market capitalization of C$5.07 million, a price-to-earnings ratio of -0.64 and a beta of 1.13. The company has a debt-to-equity ratio of 902.05, a current ratio of 0.80 and a quick ratio of 19.71. The stock has a 50-day moving average of C$0.05 and a 200 day moving average of C$0.08.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.